A Study to Assess the Bioequivalence of Famotidine Chewable Tablets and Film-Coated Tablets (0208-144)
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
This study will determine whether the CT formulation of famotidine taken with and without
water is bioequivalent to the FCT formulation. The primary hypothesis is that the area under
the concentration-time curve (AUC) and the maximum plasma concentration (Cmax) of a single
dose of famotidine 20 mg CT without water are equivalent to a single dose of famotidine 20 mg
FCT with water.